American Conference Institute's 10th National Forum on Fraud & Abuse in the Sale & Marketing of Drugs
March 24-25, 2010
March 24-25, 2010
Ina B. Scher, Davis & Gilbert Litigation Partner, will moderate the session, "Preserving Scientific Integrity While Avoiding Kickback Allegations for CME, Ghostwriting, and Consulting Arrangements," during the American Conference Institute's 10th National Forum on Fraud & Abuse in the Sale & Marketing of Drugs. The conference will take place on March 24-25 at the Helmsley Park Lane Hotel in New York City. The session will take place on March 24 between 2:15 - 3:30 p.m.
Among other topics, the panelists will discuss:
- Identifying the key triggers for government intervention
- Developing best-practices for separating CME and sales functions and ensuring they are free of commercial influence
- Understanding evolving industry standards and guidelines
- Validating pricing and fair market value
- Ensuring physician consultants do not have a financial interest in the success of the drug
- Developing defenses to allegations of improper and illegal kickbacks
For more information: www.americanconference.com/fadrugs.htm
